Malaria, caused by Plasmodia parasites, affects hundreds of millions of people. As purine auxotrophs, Plasmodia use transporters to import host purines for subsequent metabolism by the purine salvage pathway. Thus purine transporters are attractive drug targets. All sequenced Plasmodia genomes encode four ENTs (equilibrative nucleoside transporters). During the pathogenic intraerythrocytic stages, ENT1 is a major route of purine nucleoside/nucleobase transport. Another plasma membrane purine transporter exists because Plasmodium falciparum ENT1-knockout parasites survive at supraphysiological purine concentrations. The other three ENTs have not been characterized functionally. Codon-optimized Pf-(P. falciparum) and Pv-(Plasmodium vivax) ENT4 were expressed in Xenopus laevis oocytes and substrate transport was determined with radiolabelled substrates. ENT4 transported adenine and 2 -deoxyadenosine at the highest rate, with millimolar-range apparent affinity. ENT4-expressing oocytes did not accumulate hypoxanthine, a key purine salvage pathway substrate, or AMP. Micromolar concentrations of the plant hormone cytokinin compounds inhibited both PfENT4 and PvENT4. In contrast with PfENT1, ENT4 interacted with the immucillin compounds in the millimolar range and was inhibited by 10 μM dipyridamole. Thus ENT4 is a purine transporter with unique substrate and inhibitor specificity. Its role in parasite physiology remains uncertain, but is likely to be significant because of the strong conservation of ENT4 homologues in Plasmodia genomes.
INTRODUCTION
Malaria affects hundreds of millions of people annually [1, 2] . Five species from the genus Plasmodium cause human malaria. Like many other protozoan parasites, they are unable to synthesize purines de novo. Rather, they rely on purine import from the host cell through transporters in the parasite plasma membrane and purine modification through the purine salvage pathway for nucleic acid synthesis [3, 4] . Thus purine transporters are potential chemotherapeutic targets, and they may also mediate uptake of potential antimalarial compounds [5] .
To date, the majority of Plasmodium purine transport studies have focused on PfENT1 (where Pf is Plasmodium falciparum and ENT is equilibrative nucleoside transporter), also named PfNT1 (PF13_0252). Transport studies of PfENT1 heterologously expressed in Xenopus laevis oocytes show that PfENT1 is a low-affinity purine transporter with broad specificity for many nucleobases and nucleosides [6] [7] [8] [9] [10] . Other studies in Xenopus oocytes [11] and PfENT1-knockout parasites [12] have reported conflicting conclusions on the affinity and substrate specificity of PfENT1 based on radiolabelled substrateuptake experiments. However, it was demonstrated that some of the reported kinetic uptake data were strongly influenced by metabolism of the radiolabelled substrate in the oocyte and did not reflect transport as proposed previously [9, 13] . PfENT1 is expressed in blood-stage parasites at the parasite plasma membrane and is the main transporter mediating purine uptake for purine salvage pathways in cultured parasites [8] . Knockouts of the gene encoding PfENT1 in parasites indicate that PfENT1 is essential for parasite survival at physiological purine levels found in human serum [14, 15] . However, the parasite plasma membrane must contain alternative transport mechanisms because PfENT1-knockout parasites survive in media containing supraphysiological purine levels. Furthermore, PfENT1-knockout parasites released from the host erythrocytes transport purine nucleobases and nucleosides [12, 14, 15] . Finally, AMP and the immucillin class of compounds, which are purineanalogue compounds and are potent inhibitors of Plasmodium PNP (purine nucleoside phosphorylase), are not substrates of PfENT1 [4, 9] .
P. falciparum and the related parasite Plasmodium vivax (Pv), which together account for the majority of malaria cases worldwide, encode four members of the ENT family [16] . These have been designated PfENT1-PfENT4 or PvENT1-PvENT4 based on phylogenetic analysis [5] . Localization studies of epitope-tagged PfNT2 (MAL8P1.32 or PfENT2) in transgenic parasites show that its gene product is found in the parasite endoplasmic reticulum; however, its capacity to transport purines has not been demonstrated [17] . The localization and functions of PfENT3 (PF14_0662), PfENT4 (PfA0160c) and the ENTs from P. vivax remain unexplored. PfENT4 homologues with greater than 50 % sequence identity are also present in the genomes of P. vivax (PVX_081595), Plasmodium knowlesi (PKH_021010), Plasmodium chabaudi (PCHAS_020830), Plasmodium yoelii (PY06526) and Plasmodium berghei (PBANKA_020990). Expression studies in synchronized parasite cultures show that PfENT4 mRNA has a maximum expression at 20-25 h and then falls slightly as the parasites mature from the trophozoite to schizont stages [16, 18, 19] . PfENT4 mRNA is also expressed in blood-stage parasites isolated from malaria patients, but did not show significant differences among the three distinct transcriptional/metabolic states [20, 21] . MS-based expression studies have identified PfENT4 peptide fragments in several life cycle stages, including trophozoites, early schizont, schizont rupture, sporozoites and late-stage gametocytes [22, 23] . However, the levels of ENT4 protein expression during the intraerythrocytic growth cycle are unknown.
The present paper describes the characterization of PfENT4 and PvENT4 expressed in Xenopus oocytes. Previous attempts to express PfENT4 from mRNA with the native P. falciparum codon usage in Xenopus oocytes were unsuccessful [8] .
To obtain expression in oocytes, Xenopus codon-optimized versions of the PfENT4 and PvENT4 genes were synthesized. Our studies revealed that PfENT4 and PvENT4 have low affinity for adenine, adenosine and 2 -deoxyadenosine, and no capacity to transport hypoxanthine or AMP. [5,6- 3 H]uracil (33.8 Ci/mmol) were purchased from SigmaAldrich. At the start of these experiments, the purity of each radiolabelled reagent was established by HPLC. NBMPR (nitrobenzylmercaptopurineriboside) (10 mM), dipyridamole (10 mM), isopentenyladenine (200 mM), trans-zeatin (200 mM) and cis-zeatin (200 mM) were purchased from Sigma-Aldrich and were dissolved in DMSO as stock solutions. The immucillins were gifts from Dr Peter C. Tyler and Dr Gary B. Evans at Industrial Research Ltd (Lower Hutt, New Zealand); the compounds were dissolved in transport buffer before use. All other reagents were purchased from Sigma-Aldrich or Thermo Fisher Scientific.
Synthetic gene construct of PfENT4 and PvENT4 as a template for mRNA synthesis
The coding sequence of hypothetical proteins PfA0160c and PVX_081595 from the PlasmoDB were optimized for codon usage in X. laevis using Gene Designer ® software (DNA2.0). The construct included a BamHI restriction site at the 5 end, a Kozak consensus sequence, the optimized gene and a 3 EcoRI restriction site (Supplementary Figure S1 at http://www.BiochemJ.org/bj/ 446/bj4460179add.htm). The construct was subcloned into the pXOON plasmid using the BamHI/EcoRI restriction enzymes and T4 DNA ligase. The pXOON plasmid, which is the same as the pXOOM plasmid [24] except for a different multiple cloning site, contains the 5 and 3 untranslated regions for the Xenopus β-globin gene which enhances heterologous expression in oocytes. The pXOON plasmid containing either PfENT4 or PvENT4 were linearized with the NheI restriction enzyme. Capped mRNAs were synthesized with the mMESSAGE mMACHINE ® kit (Ambion) and purified using the MEGAClear kit (Ambion). Recovered mRNA was dissolved in DEPC (diethyl pyrocarbonate) (Sigma) -treated water and diluted to a concentration of 1 μg/μl.
Xenopus oocyte expression of PfENT4 and PvENT4 and radiolabelled flux assay
Female X. laevis frogs were obtained from Nasco and approved for use by the Albert Einstein College of Medicine Institutional Animal Care and Use Committee (Protocol #20110905). Stage V or VI defolliculated Xenopus oocytes were prepared as described previously [10] and were injected with 23 nl of DEPC-treated water (hereinafter referred to as 'H 2 O-injected oocytes') or mRNA for PfENT4 or PvENT4 (23 ng). Radiolabelled substrateuptake assays were performed 3 or 4 days after injection. For each experiment, radiolabelled substrate uptake by control H 2 Oinjected oocytes was performed with the same batch of oocytes and at the same time as uptake into mRNA-injected oocytes was measured. Thus each experiment included its own control H 2 Oinjected oocytes. For the assay, between four and ten oocytes were incubated in 480 μl of E1 transport buffer (140 mM NaCl, 2.8 mM KCl, 2 mM MgCl 2 , 1 mM CaCl 2 and 10 mM Hepes, pH 7.4 with NaOH) plus radiolabelled substrate at room temperature (22) (23) (24) (25) • C). Other experimental conditions are noted as necessary. In the experiments measuring substrate uptake at pH 6.5, 6.0 and 5.5, the E1 buffer was made with 10 mM Mes rather than Hepes. In the experiments measuring uptake in sodium-free buffer, the E1 buffer was made with 140 mM choline chloride rather than NaCl (pH 7.4 with KOH).
Substrate flux was terminated by washing the oocytes five times in 500 μl of ice-cold E1 buffer. The washes were completed in 15 s. Oocytes were transferred into individual scintillation vials and solubilized in 300 μl of 5% (w/v) SDS. Some competition experiments were performed by pooling eight oocytes together into one vial and solubilizing them in 1 ml of 5 % (w/v) SDS; they are noted in the text. Radioactivity was determined using a Tri-Carb 2910TR liquid-scintillation counter (PerkinElmer). All uptake experiments were repeated in at least two batches of oocytes from separate frogs.
Uptake into H 2 O-injected oocytes was often subtracted from the uptake into oocytes expressing PfENT4 or PvENT4 and these subtracted values are referred to as 'backgroundsubtracted'. For the 1 h accumulation experiment (in Figure 2) , AMP uptake was measured in the presence and absence of the 5 -ectonucleotidase inhibitor α,β-methylene-ADP (250 μM). For the competition experiments (in Figure 9) , the oocytes were incubated with 150 nM [ 3 H]adenine plus the indicated concentration of compound. DADMe-ImmG contained 2 molar equivalents of HCl and the 10 mM Hepes transport buffer was insufficient for buffering; thus experiments with DADMe-ImmG were performed in an iso-osmotic buffered solution containing 30 mM Hepes with the pH adjusted to 7.4 and a compensating reduction in the NaCl concentration. [42] and the schematic image was generated using the TOPO2 program (http://www.sacs.ucsf.edu/TOPO2/). 4 , 136.9 mM NaCl and 8.1 mM Na 2 HPO 4 , pH 7.4) (CellGro) to lyse the erythrocytes, followed by washing in DPBS as described previously [4] . The other set was used as intact infected erythrocytes. Erythrocytes, infected erythrocytes and saponinreleased parasites were placed in purine-free medium for 30 min, then incubated with 50 nM [ 3 H]adenine for 2 h and washed twice with ice-cold buffer, and the samples were frozen until further use. Purine metabolites were extracted, fractionated and detected as described in detail previously [4, 9] . Briefly, following uptake, cells were homogenized in DEPC-treated water and treated with perchloric acid to remove nucleic acids and proteins. Purines were extracted using a YM10 Centricon spin column (Amicon) and analysed using a reverse-phase ion-pair HPLC system [Luna C 18 (2) , 150 mm×4.6 mm, 3 μm; Phenomenex]. Metabolite analysis was performed using HPLC as described elsewhere [4] . The eluant was monitored at 254 nm and the flow rate was 1 ml/min. Fractions were collected every 1 min for 30 min and subjected to liquid-scintillation counting. Radiolabelled peaks were identified on the basis of UV detection of purine standards.
Metabolic labelling and determination of adenine metabolites in cells

Figure 2 Uptake of nucleobases and nucleosides by oocytes expressing PfENT4 or PvENT4
(A) Uptake of 1.5 μM radiolabelled substrates by oocytes expressing PfENT4 (black bars) or PvENT4 (grey bars) following 1 h of incubation. Results are mean + − S.E.M. uptake of 9-38 oocytes after adjustment for control (H 2 O-injected oocytes). These oocytes were from at least three different oocyte isolations, and all points are pooled to calculate the mean. Values before normalization can be found in Supplementary Table S1 at http://www.BiochemJ.org/bj/446/bj4460179add.htm along with values for uptake by H 2 O-injected oocytes. We cannot distinguish whether the differences in uptake between PfENT4-and PvENT4-expressing oocytes are due to differences in the level of protein expression or to intrinsic differences in the transport properties of the two transporters. *P < 0. 
Data analysis
Statistical tests and curve-fitting used GraphPad Prism version 5.02 for Windows. Non-linear regression analyses included Michaelis-Menten kinetics and single-and two-site sigmoidal dose-response curves to determine IC 50 values. K i values were determined using the method of Cheng and Prusoff [25] . Results are presented as means + − S.E.M. or means + − S.D.
RESULTS
Functional characterization of PfENT4 and PvENT4
The predicted TM (transmembrane) topology of PfENT4 and PvENT4 is characteristic for ENT family members with 11 TM segments and a large cytosolic loop between TM domains 6 and 7 ( Figure 1 ). X. laevis oocytes provide an excellent expression system for nucleoside/nucleobase-transport studies [26, 27] . To assess whether oocytes injected with PfENT4 or PvENT4 mRNA transport nucleosides and nucleobases, we performed radiolabelled substrate-uptake assays. As an initial screen, oocytes were incubated in the presence of 1.5 μM radiolabelled compounds and substrate accumulation was measured after 1 h (Figure 2A and Supplementary Table S1 at http://www.BiochemJ.org/bj/446/bj4460179add.htm). Oocytes injected with PfENT4 or PvENT4 mRNA had greater uptake of the purine nucleobase adenine and the purine nucleosides adenosine, 2 -deoxyadenosine, 2 -deoxyguanosine and inosine than H 2 O-injected oocytes. There was no observed uptake of hypoxanthine ( Figure 2A and Supplementary Table S1 ). Oocytes have a 5 -nucleotidase which can convert AMP into adenosine [4] . This 5 -nucleotidase activity can be blocked by the addition of 250 μM α,β-methylene-ADP. AMP transport was 3 H]adenine by oocytes expressing PfENT4 or PvENT4 during 1 h of incubation at the indicated pH. Uptake at each pH was background-subtracted and normalized to the uptake at pH 7.4 (100 %). Results are means + − S.E.M. of at least 12 oocytes pooled from three separate experiments. *P < 0.01 compared with uptake at pH 7.4 by one-way ANOVA, with Dunnett's post-hoc analysis. (B) Oocytes expressing PfENT4 or PvENT4 were incubated for 1 h in the presence of buffer containing either Na + or choline + , with pH adjusted to 7.4 with either NaOH or KOH respectively. Uptake was background-subtracted and normalized to give the percentage of uptake in Na + buffer (100 %). Results are means + − S.E.M. of 12-15 oocytes pooled from three separate experiments. Uptake values in the choline + buffer are statistically significantly different from uptake values in the Na + buffer (Student's t test, P < 0.01). Non-background subtracted values can be found in Supplementary Tables S2 and S3 at http://www.BiochemJ.org/bj/446/bj4460179add.htm.
not observed in the presence of α,β-methylene-ADP (Figure 2A and Supplementary Table S1 ). Oocytes expressing PfENT4 and PvENT4 displayed uptake of thymidine. However, PvENT4-expressing oocytes exhibited less accumulation of thymine and uracil than H 2 O-injected oocytes, although this trend is not statistically significant.
Adenine, adenosine and 2 -deoxyadenosine uptake was time-dependent, with accumulation increasing up to 120 min ( Figures 2B-2D ). Adenine and adenosine uptake was greater in PvENT4-expressing oocytes than in PfENT4-expressing oocytes; 2 -deoxyadenosine uptake was similar for both transporters ( Figures 2B-2D) .
Secondary active transport proteins use Na Table S2 at http://www. BiochemJ.org/bj/446/bj4460179add.htm) or in a solution in which choline chloride replaced sodium chloride ( Figure 3B and Supplementary Table S3 at http://www.BiochemJ.org/bj/446/ bj4460179add.htm). Adenine transport was inhibited at lower pH values, and the effect was more pronounced for PfENT4 than for PvENT4. A similar trend was observed when adenosine was used as the substrate (results not shown). This observation rules out co-transport of protons and purines. Although replacing sodium in the transport buffer with choline caused significant inhibition of adenine transport by PfENT4 and PvENT4 (26 % and 18 % inhibition, Student's t test P < 0.01), we would have expected complete inhibition of purine uptake if PfENT4 or PvENT4 were sodium-coupled transporters.
To investigate the kinetic parameters of purine transport, we measured the concentration-dependent uptake of both adenosine and adenine (Figure 4 ) at 1 h, which is within the linear uptake range for both transporters and substrates. Uptake was not saturable at concentrations up to 10 mM, thus obtaining accurate K m values was not possible in this assay. Alternatively, we used unlabelled substrate to competitively inhibit radiolabelled substrate uptake to obtain estimates of the substrate K i , which provided a measurement of a compound's apparent affinity for transport [8] . Unlabelled adenosine inhibited [ 3 H]adenosine transport and the data were fitted to a one-site competition model ( Figure 5A and 5B) with mean + − S.E.M. K i values being 2.2 + − 1.0 mM (n = 3) for PfENT4 and 1.0 + − 0.2 mM (n = 3) for PvENT4 (Table 1) . Similarly, unlabelled 2 -deoxyadenosine inhibited 2 -[
14 C]deoxyadenosine uptake with mean K i values of 1.5 + − 0.1 mM for PfENT4 and 4.3 + − 0.2 mM for PvENT4 (Table 1 ). In contrast, data for adenine competitively inhibiting 5D and Table 1 ). The two sites are probably due to competition with both a metabolic enzyme and the transporter, where the site that is rate-limiting in the uptake assay depends on the substrate concentration [8] .
Adenine metabolism in oocytes and competitive inhibition of adenosine and 2 -deoxyadenosine transport with adenine
The Figure 6A) . A possible mechanism is adenine conversion into AMP by APRT (adenine phosphoribosyltransferase), with subsequent phosphorylation to ADP and ATP by adenylate kinase.
To investigate which affinity component represents inhibition at the site of transport, we measured the influx of either ]deoxyadenosine as the labelled substrate, we could estimate the K i for adenine transport because adenine, adenosine and 2 -deoxyadenosine compete for transport at ENT4, but not for metabolism via APRT. We showed previously that in oocytes adenosine is phosphorylated by adenosine kinase and then phosphorylated by adenylate kinase to ADP and ATP [9] . We observed inhibition of [ 3 H]adenosine uptake by increasing concentrations of unlabelled adenine in the low-millimolar range ( Figure 6B ). The calculated adenine K i values were 9 + − 2 mM for PfENT4 and 15.0 + − 0.5 mM for PvENT4. Similarly, analysis Figure 6C ). These relatively high K i values suggest that the low apparent affinity component of adenine uptake was attributable to transport and the component with an apparent K i less than 10 μM was likely to be due to competition at the metabolic enzyme, APRT. [ 3 H]adenine. Purines were extracted and analysed by HPLC. Uninfected erythrocytes completely metabolized adenine to phosphorylated nucleotides, mainly ATP, through the action of APRT and adenylate kinase ( Figure 7A ). This is expected since normal uninfected erythrocytes contain ∼2 mM ATP. Infected erythrocytes metabolized adenine predominantly to phosphorylated nucleotides as well as to other purines such as hypoxanthine and inosine ( Figure 7B ). Of note, in the infected erythrocytes, much of the metabolized adenine was present as AMP and ADP compared with the uninfected erythrocytes where the predominant nucleotide was ATP (compare Figures 7A and  7B) . Isolated parasites accumulated [ 3 H]adenine mostly as unmetabolized adenine with small amounts of adenine nucleotides ( Figure 7C ). Thus adenine was not rapidly incorporated into the nucleoside/nucleotide pool within the parasites in the absence of the erythrocyte. The presence of small amounts of tritium label in other purine metabolites in the saponin-released parasites may result from a small percentage of unlysed infected erythrocytes contaminating the free parasites. Alternatively, there might be a low-efficiency P. falciparum APRT activity, although no P. falciparum APRT gene has been identified [28] .
Adenine metabolism in parasites
Inhibition of 2 -[ 14 C]deoxyadenosine uptake with modified adenine compounds
The apparent affinities of adenine, adenosine and 2 -deoxyadenosine were low relative to other members of the ENT family of proteins (reviewed in [29] ). To investigate whether other compounds were recognized by ENT4 with higher affinity, we tested the ability of modified adenine compounds, namely the cytokinin plant hormones isopentenyl adenine, trans-zeatin and cis-zeatin, to compete with 2 -[ 14 C]deoxyadenosine uptake. All three compounds inhibited 2 -[ 14 C]deoxyadenosine uptake ( Figure 8 and Table 1 ). Isopentenyl adenine inhibited with the highest apparent affinity, with K i values of 3.3 + − 0.9 μM for PfENT4 and 9.5 + − 2.8 μM for PvENT4. Trans-zeatin had a higher affinity for PfENT4 than for PvENT4, with K i values observed to be 20 and 193 μM respectively. The apparent affinity of cis-zeatin for PfENT4 and PvENT4 appeared to be similar with observed K i values of 190 and 284 μM respectively.
Inhibition of adenine uptake by PNP transition-state analogues and ENT inhibitors
We sought to determine whether other substrates interacted with PfENT4 or PvENT4 expressed in oocytes. The immucillins are nucleoside analogue inhibitors of PNP; however, they are not substrates for PfENT1 [9] . Competition experiments indicated that the immucillins inhibited [ 3 H]adenine uptake, but only in the millimolar range, similar to the affinity for the other purines tested (Figure 9 ). Immucillin-H at 7 mM caused significantly greater inhibition of PfENT4 than at 2 mM, suggesting that the dose-response relationship has a steep Hill slope coefficient if it were to be analysed as a sigmoidal function. Plasma concentrations of uric acid, a product of human purine catabolism, is hypothesized to be increased during P. falciparum infection, creating a steep concentration gradient in the circulation, which could be potentially transported into parasites [30] . Urate, the conjugate base of uric acid, was not recognized by ENT4 because 500 μM urate did not compete for adenine transport (Figure 9 ). Adenine uptake was inhibited by ∼80 % by 10 μM dipyridamole, an inhibitor of other ENT proteins, but was insensitive to 10 μM NBMPR (Figure 9 ). Hypoxanthine did not inhibit adenine uptake, confirming that hypoxanthine is not transported or recognized by PfENT4 or PvENT4 (Figure 2A ).
DISCUSSION
Resolving transport and metabolism
In the present study, we sought to identify the function and substrate specificity of ENT4 homologues from P. falciparum and P. vivax by heterologously expressing Xenopus codonoptimized ENT4 transcripts in Xenopus oocytes. Our results indicate that PfENT4 and PvENT4 are low-affinity adenine, adenosine and 2 -deoxyadenosine transporters ( Figures 2, 4 and 5). They can also transport some guanine-derived nucleobases and nucleosides. Studies of nucleoside/nucleobase transport are complicated by the fact that many of these substrates are metabolized once inside the cell to potentially non-transportable compounds. This may affect kinetic analysis of the observed flux depending on whether transport or metabolism is the rate-limiting step [9, 13] may relate to the transport rate differences between adenosine and 2 -deoxyadenosine, but what is clear is that adenine competes with adenosine at one site with a millimolar apparent K i value that is attributable to transport and not metabolism. This implies that adenine has a low affinity for PfENT4 and PvENT4. Of note, none of the four purine-uptake pathways defined by Quashie et al. [12] in isolated P. falciparum parasites have affinities consistent with those of PfENT4. As has been pointed out previously, it is likely that in their studies in P. falciparum parasites, the metabolic enzymes and not the transporters were rate-limiting in uptake experiments, thus their calculated affinities are those of the various metabolic enzymes and not the transporters [9, 13] .
For a number of the substrates tested, the uptake was greater in PvENT4-expressing oocytes than in PfENT4-expressing oocytes (Figure 2A ). These differences could be due to differences in the level of expression of the two proteins. This might be due Table 1 ).
to differences in the codon-optimization process used to generate the DNA constructs or may be due to the differences in amino acid sequence between the two ENT4 homologues that are 64 % sequence identical. Alternatively, they may represent differences in the substrate translocation rates for the two ENT4 homologues. Without being able to accurately quantify the levels of protein expression in each experiment, we cannot distinguish between these two possibilities.
The rate of purine transport by oocytes expressing PfENT4 and PvENT4 was significantly lower than for oocytes expressing PfENT1. This could be due to differences in the level of protein expression and/or to differences in the rate of transport by the specific proteins. At present we cannot distinguish between these alternatives.
ENT4 specificity
For PfENT4, adenine and 2 -deoxyadenosine transport was similar and 7-, 9-and 10-fold greater than adenosine, guanine and guanosine respectively (Figure 2A) . Purine transport studies in saponin-released ATP-depleted pfENT1 knockout parasites have demonstrated adenine uptake, but no measurable uptake of adenosine, guanine or guanosine [15] . We infer that PfENT4 may account for the observed adenine uptake in the PfENT1-knockout parasites; but PfENT4 may be expressed at low levels in the parasites making the uptake of adenosine, guanine and guanosine undetectable under the experimental conditions.
Ion effects on ENT4 function
Adenine transport via PfENT4/PvENT4 was inhibited by decreasing pH. This implies that neither transporter is a proton-purine co-transporter. The pK a for this inhibition was between pH 5.5 and 6.0 ( Figure 3A) . This suggests that the imidazole moiety of a critical histidine residue(s) is being titrated across the range of pH values, thereby inhibiting transporter function. Another possibility is that this transporter is a proton antiporter, although we think that this is less likely because we would have expected the PvENT4 transport process to be more sensitive to pH inhibition because of its higher rates of adenine transport. The molecular basis of this pH-dependent inhibition is currently under investigation.
We observed that adenine uptake into oocytes bathed in a choline chloride buffer was less than in oocytes bathed in a sodium chloride buffer. This may reflect a weak interaction of choline with the ENT4 proteins resulting in inhibition of adenine uptake. Given that 140 mM choline only inhibited transport by 18-26 % ( Figure 3B ), we did not investigate this effect in greater detail.
Inhibitor specificity of ENT4
In contrast with PfENT1, PfENT4 and PvENT4-mediated uptake of adenine was inhibited by the classical nucleoside transport inhibitor dipyridamole. Dipyridamole inhibits growth of chloroquine-resistant P. falciparum parasites in vitro, although the reported efficacy varies with IC 50 values ranging from 30 nM [31] to 13.9 μM [32] . Dipyridamole inhibits recombinant P. falciparum phosphodiesterase-1; however, the mechanism of dipyridamole's antiparasitic activity in vitro is not known [33] . Previous work from our laboratory and others have demonstrated that PfENT1 is insensitive to dipyridamole [6, 8, 10] , thus dipyridamole's inhibitory effect must be exerted through another mechanism, and ENT4 may be contributing to that mechanism. Similar to PfENT1, neither PfENT4 nor PvENT4 were inhibited by NBMPR.
Adenine metabolism in P. falciparum
Of the radiolabelled substrates tested, adenine and 2 -deoxyadenosine were transported the fastest by PfENT4 and PvENT4. It is not clear whether either of these substrates play a role in purine salvage during the intraerythrocytic growth stages of P. falciparum. Human serum has low concentrations of 2 -deoxyadenosine and the erythrocyte lacks a nucleus, so 2 -deoxyadenosine is not likely to be a significant nutrient for the intraerythrocytic parasites. Additionally, human erythrocytes have <0.4 μM adenine in their cytoplasm [34] . Our metabolic labelling data ( Figure 7C ) support the hypothesis that P. falciparum does not efficiently use adenine in purine salvage for nucleic acids.
In the absence of the erythrocyte, adenine was only converted into nucleotides at a very low level and accumulated inside the parasites mainly as unmetabolized adenine [3] . We cannot rule out that the conversion of labelled adenine into nucleotides was due to a minor contamination of the isolated parasites by infected erythrocytes.
We demonstrated previously that P. falciparum is capable of salvaging AMP from the erythrocyte cytosol as an alternative purine source [4] . Thus the metabolic pattern observed in infected erythrocytes is likely to be due to erythrocytic APRT activity and AMP transport. Although previous reports described an APRT-like activity in purified P. falciparum parasite lysates and saponin-released parasites, the observed purine incorporation occurs at rates consistent with minor contamination of the samples with erythrocyte cytoplasm [35, 36] . Genome-wide searches of apicomplexan parasites failed to find APRT genes, which are conserved across other species [28] .
The results of the present study suggest that purine substrates for the purine salvage pathway, although recognized and transported by PfENT4 and PvENT4, may not be the primary substrates for these transporters in vivo during the intraerythrocytic stages. Given the broad expression pattern of ENT4 during the Plasmodium life cycle, it may play a role in purine salvage, for example, during replication in hepatocytes or within the mosquito. Alternatively, other yet to be identified compounds may be the true substrates of ENT4.
Of note, the energetic state of infected erythrocytes appeared to be impaired compared with uninfected erythrocytes. In uninfected erythrocytes, adenine was almost completely converted into ATP ( Figure 7A ). In contrast, in infected erythrocytes, approximately one-half of the radiolabelled adenine was present as AMP or ADP ( Figure 7B ). We infer that a lack of sufficient energy production in the trophozoite-infected erythrocyte cytoplasm diminished their ability to convert adenine into AMP and then into ADP.
Cytokinins are ENT4 ligands
The plant cytokinin hormones, adenine derivatives, inhibited 2 -deoxyadenosine uptake with apparent affinities 10-1000-fold higher than adenine, adenosine or 2 -deoxyadenosine. We infer that the inhibition of 2 -deoxyadenosine uptake is due to transport of these adenine derivatives, but, lacking radiolabelled compounds, we could not demonstrate uptake of these substances into the oocytes. The interaction of these adenine derivative with PfENT4 and PvENT4 was surprising, especially since hypoxanthine, which also differs at the C-6 carbon position in the purine ring, was not recognized by PfENT4 or PvENT4 either by direct transport or in competition with adenine. This implies that substrate recognition by these transporters is sensitive to the chemical moiety at the purine C-6 carbon position.
Although the physiological relevance of the relatively high affinity of PfENT4 and PvENT4 for the cytokinin compounds is not known, purine transporters in other organisms are involved in the translocation of these compounds [37] [38] [39] . Additionally, isopentenyl adenine was reported to be lethal to in vitro growth of P. falciparum FCR-3 strain parasites with an IC 50 of 8.34 μM [40] . PfENT4-mediated transport to an intracellular target may give rise to the reported inhibition of growth.
AMP is not transported by ENT4
One motivation for expressing and characterizing PfENT4 and PvENT4 was to determine whether these transporters are responsible for mediating uptake of AMP and/or the immucillin class of compounds. Previous work showed that PfENT1 does not transport these compounds [4, 9] . In the present study, we have shown that AMP was not transported by PfENT4 or PvENT4. In contrast, the immucillin compounds were recognized with millimolar affinity by these two transporters as was evident from their ability to inhibit adenine uptake ( Figure 9 ). Of note, immucillin H had a stronger interaction with PfENT4 than with PvENT4. The basis for this is unclear, but may relate to amino acid sequence differences between the two ENT4 homologues. It is not clear whether the ENT4 transporters are the predominant route for the uptake of immucillins to reach their target, PNP, in the parasite cytoplasm [41] .
In conclusion, we showed that PfENT4 and PvENT4 are lowaffinity adenine, adenosine and 2 -deoxyadenosine transporters. Their purine substrate specificity is distinct from that of PfENT1. Whether the physiological function of ENT4 is for purine uptake for the purine salvage pathway or for transport of other important substrates, such as the cytokinins, remains to be determined. If the primary substrate transported by parasite ENT4s is critical to the parasite's growth and survival then that might explain why Plasmodium, and potentially other protozoan parasites, encode multiple nucleoside transporters. We speculate that nucleoside transporters may not only satisfy nutritional requirements for the parasite, but also be important proteins for translocating other potentially important molecules that are yet to be identified. 
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